Screening for diabetes, impaired glucose tolerance, and cardiovascular risk in primary care: a Northland, New Zealand pilot study.
作者： Nick Chamberlain , Bronwyn White
DOI:
关键词:
摘要: AIM To describe the results of a pilot project diabetes screening in high risk general practice population. METHOD Adequacy follow-up fasting plasma glucose (FPG) tests and recording cardiovascular scores was analysed, prevalence impaired tolerance (IGT) calculated using WHO diagnostic criteria. RESULTS In registered population 28,000, 1251 people were screened for which 1129 (90.2%) completed pathway. Diabetes detected 3.6% (n=24) Maori 2.0% (n=9) non-Maori. There no statistical difference between uptake to oral (OGT) Eighty percent (n=1002/1251) had Cardiovascular Risk Assessment (CVRA). This occurred less frequently (76.6%, 576/752) compared non-Maori (85.4%, 426/499), p=0.0001. CONCLUSION The consequences low OGT ranged from underestimated estimates CVD scores. Increased raised FPGs is required. Because CVRA lower Maori, caution advised against reliance on programmes as sole mechanism identify with or IGT. Further investigations into use HbA1c test are recommended groups.
cabdirect.org参考文章(13)
Dale Bramley, Sue Furness, Robyn Whittaker, Sue Wells, Natasha Rafter, Alistair Stewart, Rod Jackson, Paul Roseman, Vanessa Selak, Will a web-based cardiovascular disease (CVD) risk assessment programme increase the assessment of CVD risk factors for Maori? The New Zealand Medical Journal. ,vol. 119, ,(2006)
N Waugh, G Scotland, P McNamee, M Gillett, A Brennan, E Goyder, R Williams, A John, Screening for Type 2 Diabetes: Literature Review and Economic Modelling Health Technology Assessment. ,vol. 11, ,(2007) , 10.3310/HTA11170
J. M Lawrence, P. Bennett, A. Young, A. M Robinson, Screening for diabetes in general practice: cross sectional population study. BMJ. ,vol. 323, pp. 548- 551 ,(2001) , 10.1136/BMJ.323.7312.548
Ak Viswanath, O Pereira, S Philip, KC Mchardy, Diagnosing diabetes mellitus: contemporary use of the oral glucose tolerance test in a regional diabetes centre Practical Diabetes International. ,vol. 23, pp. 287- 290 ,(2006) , 10.1002/PDI.985
Tim Kenealy, C Raina Elley, Bruce Arroll, Screening for diabetes and prediabetes The Lancet. ,vol. 370, pp. 1888- 1889 ,(2007) , 10.1016/S0140-6736(07)61792-9
C. C. Cowie, K. F. Rust, D. D. Byrd-Holt, M. S. Eberhardt, K. M. Flegal, M. M. Engelgau, S. H. Saydah, D. E. Williams, L. S. Geiss, E. W. Gregg, Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population National Health and Nutrition Examination Survey 1999–2002 Diabetes Care. ,vol. 29, pp. 1263- 1268 ,(2006) , 10.2337/DC06-0062
L. A. Leiter, A. Barr, A. Belanger, S. Lubin, S. A. Ross, H. D. Tildesley, N. Fontaine, Diabetes Screening in Canada (DIASCAN) Study: Prevalence of undiagnosed diabetes and glucose intolerance in family physician offices Diabetes Care. ,vol. 24, pp. 1038- 1043 ,(2001) , 10.2337/DIACARE.24.6.1038
E Goyder, S Wild, C Fischbacher, J Carlisle, J Peters, Evaluating the impact of a national pilot screening programme for type 2 diabetes in deprived areas of England. Family Practice. ,vol. 25, pp. 370- 375 ,(2008) , 10.1093/FAMPRA/CMN054
D Bramley, S Furness, Robyn Whittaker, Natasha Rafter, Alistair Stewart, Rodney Jackson, P Roseman, Linda Wells, Vanessa Selak, Gaps in primary care documentation of cardiovascular risk factors. The New Zealand Medical Journal. ,vol. 121, pp. 24- 33 ,(2008)
Ian Sheerin, Greg Hamilton, Alistair Humphrey, Alf Scragg, Issues in the assessment of cardiovascular risk in selected general practices in Canterbury, New Zealand. The New Zealand Medical Journal. ,vol. 120, ,(2007)